US allows pharmacies to make unproven peptides without FDA approval
HHS will stop enforcing a ban on small pharmacies compounding six unproven peptides previously available only illegally.
HHS will exercise enforcement discretion for six peptides. Small compounding pharmacies can now make them without FDA review.
Previously, the peptides came from gray market sources overseas with poor quality control. Peptides are chains of amino acids with powerful effects in the body.
They are promoted for wellness despite little evidence of safety or effectiveness. The policy applies only to small 503A compounding pharmacies, not larger producers.
Public Citizen and other groups say the move undermines FDA authority and risks patient harm. Supporters argue pharmacy compounding is safer than illegal sources.
- 6 peptides
- Peptides approved for discretion
- Small 503A compounding pharmacies only
- Pharmacy type allowed
- Robert F. Kennedy Jr.
- Health Secretary supporter
- Against unwinding restrictions
- FDA scientist recommendation
Why it mattersUnproven substances now enter the legitimate pharmacy supply without standard drug testing, potentially exposing consumers to unknown risks.
AustraliaNo direct Australian effect yet, but Australian importers of wellness peptides may see supply shifts if US pharmacy production meets global demand.
✓ Claims checked against the source and corrected before publish. checked 2 h ago
Open this story in InSnip →
